Sifri Ziad C, Nayak Natasha, Homnick Adena T, Mohr Alicia A, Yonclas Peter, Livingston David H
Division of Trauma and Critical Care, Department of Surgery, UMDNJ-NJMS, Newark, New Jersey 07101, USA.
J Trauma. 2011 Dec;71(6):1605-10. doi: 10.1097/TA.0b013e31822b3728.
Previous studies proposed that repeat head computed tomography (RHCT) is of no value in patients with a minimal head injury (MHI) and normal neurologic examination (NE). The goal of our study was to investigate the value of RHCT in patients with MHI with an abnormal NE.
A retrospective chart review of adult patients presenting to a Level I trauma center from July 2002 to December 2006 with MHI was performed. Demographics, injury severity, and HCT findings were collected. Patients with an abnormal NE at the time of RHCT were divided into three subgroups: acute deterioration NE (AD-NE), persistently abnormal NE (PA-NE), and unknown NE (U-NE). Changes in the management and outcomes after RHCT were compared.
One hundred seven patients had a MHI with an abnormal NE. Of those, seven (6.5%) had a change in management after RHCT. At the time of RHCT, 68 patients (63%) had a PA-NE, 21 AD-NE, and 18 U-NE. Six patients (29%) with AD-NE, 1 patient (6%) with an U-NE, and no patients with PA-NE required changes in management after RHCT. Compared with a RHCT, NE had higher positive and negative predictive values in determining the need for management changes.
Of all patients with MHI with an abnormal NE at the time of RHCT, 63% had a PA-NE. Although a RHCT is beneficial to patients with an acutely deteriorating or U-NE, it appears to be of little value in patients with a PA-NE. Compared with RHCT, serial NE may be a stronger predictor for the need for intervention in patients with MHI.
既往研究表明,重复头颅计算机断层扫描(RHCT)对轻度颅脑损伤(MHI)且神经学检查(NE)正常的患者没有价值。我们研究的目的是调查RHCT在NE异常的MHI患者中的价值。
对2002年7月至2006年12月在一级创伤中心就诊的成年MHI患者进行回顾性病历审查。收集人口统计学、损伤严重程度和HCT检查结果。RHCT时NE异常的患者分为三个亚组:急性恶化NE(AD-NE)、持续异常NE(PA-NE)和不明NE(U-NE)。比较RHCT后管理和结局的变化。
107例患者为MHI且NE异常。其中,7例(6.5%)在RHCT后管理发生了变化。在RHCT时,68例患者(63%)为PA-NE,21例为AD-NE,18例为U-NE。6例(29%)AD-NE患者、1例(6%)U-NE患者在RHCT后需要改变管理,而PA-NE患者无此情况。与RHCT相比,NE在确定是否需要改变管理方面具有更高的阳性和阴性预测价值。
在RHCT时所有MHI且NE异常的患者中,63%为PA-NE。虽然RHCT对急性恶化或U-NE患者有益,但对PA-NE患者似乎价值不大。与RHCT相比,系列NE可能是MHI患者是否需要干预的更强预测指标。